Literature DB >> 15494049

Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study.

Sarman Singh1, Amol J Pandit.   

Abstract

PROBLEM: Toxoplasmosis is a major cause of congenitally acquired infections causing high degree of morbidity and mortality in the newborns. METHODS OF STUDY: IgG avidity method was used to distinguish the recent and more than 4 months old infection in a prospective cohort study for the first time in India. One hundred and eighty pregnant women presented in their first 4 months of pregnancy were included in this study. Their sera were tested for anti-Toxoplasma gondii antibodies using direct agglutination test, immunoglobulin (Ig)G and IgM-enzyme-linked immunosorbent assay, IgM-immunosorbent agglutination assay and VIDAS-IgG avidity.
RESULTS: Overall IgG seroprevalence rate of toxoplasmosis was 45%. Only seven women (3.3%) were found to have IgM antibodies and only two of these showed low IgG avidity indicating recent infection of <or=4 months duration. One woman aborted spontaneously at her fourth month of gestation. In remaining five women the recent infection could successfully be excluded by IgG avidity testing. All these women had uneventful pregnancy.
CONCLUSIONS: This study indicated that all IgM antibody positive pregnant must be tested for IgG avidity to rule out recent primary infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494049     DOI: 10.1111/j.1600-0897.2004.00222.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  24 in total

1.  Seroprevalence of Toxoplasma gondii in southern districts of Tamil Nadu using IgG-ELISA.

Authors:  G Sucilathangam; N Palaniappan; C Sreekumar; T Anna
Journal:  J Parasit Dis       Date:  2012-03-13

2.  Serological survey and risk factors associated with Toxoplasma gondii infection among HIV-infected pregnant women attending Abuja Tertiary Hospital, Nigeria.

Authors:  Maryam Muhammad Zakari; Aliyu Yabagi Isah; Richard Offiong; Thairu Yunusa; Idris Nasir Abdullahi
Journal:  Malawi Med J       Date:  2020-09       Impact factor: 0.875

3.  Use of immunoglobulin g avidity to determine the course of disease in visceral and post-kala-azar dermal leishmaniasis patients.

Authors:  Naresh Singh Redhu; Ayan Dey; Veena Balooni; Sarman Singh
Journal:  Clin Vaccine Immunol       Date:  2006-08

4.  Seroepidemiological study of toxoplasmosis in southern districts of Tamil Nadu.

Authors:  G Sucilathangam; T Anna
Journal:  J Parasit Dis       Date:  2014-08-24

5.  Seroprevalence of Toxoplasma gondii infection among pregnant women in Windhoek, Namibia, in 2016.

Authors:  Berta E van der Colf; Gert U van Zyl; Bruce H Noden; Dismas Ntirampeba
Journal:  S Afr J Infect Dis       Date:  2020-05-13

6.  Seropositivity of toxoplasmosis in antenatal women with bad obstetric history in a tertiary-care hospital of Andhra Pradesh, India.

Authors:  Munmun Das Sarkar; B Anuradha; Neelam Sharma; Rabindra Nath Roy
Journal:  J Health Popul Nutr       Date:  2012-03       Impact factor: 2.000

Review 7.  Congenital and perinatal infections: throwing new light with an old TORCH.

Authors:  Anita Shet
Journal:  Indian J Pediatr       Date:  2010-10-16       Impact factor: 5.319

8.  Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico.

Authors:  Cosme Alvarado-Esquivel; Antonio Sifuentes-Alvarez; Sergio Guadalupe Narro-Duarte; Sergio Estrada-Martínez; Juan Humberto Díaz-García; Oliver Liesenfeld; Sergio Arturo Martínez-García; Arturo Canales-Molina
Journal:  BMC Infect Dis       Date:  2006-07-13       Impact factor: 3.090

9.  Serologic prevalence of Toxoplasma gondii in Indian women of child bearing age and effects of social and environmental factors.

Authors:  Sarman Singh; Arshi Munawwar; Sugandhi Rao; Sanjay Mehta; Naba Kumar Hazarika
Journal:  PLoS Negl Trop Dis       Date:  2014-03-27

10.  Serological survey of toxoplasmosis in a district in Tamil Nadu: hospital-based study.

Authors:  G Sucilathangam; N Palaniappan; C Sreekumar; T Anna
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.